Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$147.1K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Jul 21 | TLSA | Tiziana Life Sciences Ltd | PBUY↺ | 42,357 | $0.99 | $41.9K | +<0.1% | Open the original filing on SEC.gov |
| Jul 20 | OKYO | OKYO Pharma Ltd | PBUY↺ | 25,000 | $1.40 | $35K | +0.2% | Open the original filing on SEC.gov |
| Jun 12 | TLSA | Tiziana Life Sciences Ltd | PBUY↺ | 15,000 | $1.11 | $16.7K | +<0.1% | Open the original filing on SEC.gov |
| Jun 8 | OKYO | OKYO Pharma Ltd | AGRANT | 300,000 | $1.72 | $516K | +2.9% | Open the original filing on SEC.gov |
| Jun 13, 2025 | ACUT | Accustem Sciences Inc. | PBUY | 400 | $1.10 | $440 | +<0.1% | Open the original filing on SEC.gov |
| Jun 13, 2025 | ACUT | Accustem Sciences Inc. | PBUY | 2,000 | $1.00 | $2K | +<0.1% | Open the original filing on SEC.gov |
| Jun 12, 2025 | ACUT | Accustem Sciences Inc. | PBUY | 8,991 | $0.83 | $7.5K | +0.1% | Open the original filing on SEC.gov |
| Jun 11, 2025 | ACUT | Accustem Sciences Inc. | PBUY | 28,205 | $0.39 | $11K | +0.4% | Open the original filing on SEC.gov |